Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight

Farhat Nasim24 April 2025 6:29 PM IST

Mumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...

Jubilant Chairman Cleared of Charges in Sexual Assault Case

Farhat Nasim22 April 2025 7:07 PM IST

New Delhi: Jubilant Pharmova Limited has officially announced that the allegations made against its Chairman, Shyam S Bhartia have been found to be...

As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India

Farhat Nasim22 April 2025 7:04 PM IST

New Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...

Rs 278 Cr Indemnity Claim, Inflated GMV, Board Ouster: Inside the Medikabazaar Controversy

Farhat Nasim21 April 2025 4:49 PM IST

Delhi: Medikabazaar, a leading B2B medical supply chain platform in India, became embroiled in a significant controversy involving allegations of...

Associate Professor, 8 Doctors, over 50 Pharma Giants in Dock for Unauthorised Drug Trials

Medical Ethics Breached: 9 Doctors Suspended, 50 pharma giants in dock for Unauthorised Drug Trials

Farhat Nasim21 April 2025 4:29 PM IST

A five-member panel found that the trials violated NMC and DCGI norms due to lack of regulatory approvals.

India's Father of Angioplasty Cardiologist Dr Mathew Samuel Kalarickal Passes Away at 77

Farhat Nasim18 April 2025 7:44 PM IST

New Delhi: Cardiologist Dr Mathew Samuel Kalarickal, widely revered as the 'Father of Angioplasty' in India, passed away on April 18, 2025, at Apollo...

4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry

Farhat Nasim18 April 2025 6:13 PM IST

Delhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...

Zydus Lifesciences gets USFDA nod for Glatiramer Acetate Injection for relapsing forms of Multiple Sclerosis

Zydus Loses Patent Battle Over Bladder Drug Myrbetriq In US, Jury Trial Set for 2026

Farhat Nasim17 April 2025 6:55 PM IST

New Delhi: Indian drugmaker Zydus Lifesciences has received a legal setback in the United States after the District Court of Delaware ruled in favour...

Health Ministry Bans Chlorpheniramine Phenylephrine Combo for Children Below 4, Mandates Warning Labels

Farhat Nasim17 April 2025 6:09 PM IST

New Delhi: Through a recent Gazette Notification, the Ministry of Health and Family Welfare has officially restricted the use of the widely available...

Govt Bans 35 Combination Drugs, See Full List

Farhat Nasim16 April 2025 8:36 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...

Rs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit

Farhat Nasim14 April 2025 6:43 PM IST

Hyderabad: In a strategic move to enhance operational efficiency, pharmaceutical giant Dr Reddy's Laboratories (DRL) has initiated a significant cost...

D.Pharm To Remain Minimum Qualification To Become Pharmacist in Bihar: Patna HC

Farhat Nasim12 April 2025 4:42 PM IST

Though B.Pharm and M.Pharm are higher qualifications, the court said D.Pharm as the fixed minimum can't be questioned just for seeming unwise or...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok